STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE.
作者信息
Berliner R W, Earle D P, Taggart J V, Zubrod C G, Welch W J, Conan N J, Bauman E, Scudder S T, Shannon J A
机构信息
Department of Medicine, New York University College of Medicine, New York City.
出版信息
J Clin Invest. 1948 May;27(3 Pt 2):98-107. doi: 10.1172/JCI101980.
Abstract
摘要
相似文献
1
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE.人类疟疾化疗研究。VI. 4-氨基喹啉几种衍生物的生理处置、抗疟活性及毒性
J Clin Invest. 1948 May;27(3 Pt 2):98-107. doi: 10.1172/JCI101980.
2
3
4
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. III. THE PHYSIOLOGICAL DISPOSITION AND ANTIMALARIAL ACTIVITY OF THE CINCHONA ALKALOIDS.人类疟疾化疗研究。III. 金鸡纳生物碱的生理分布及抗疟活性
J Clin Invest. 1948 May;27(3 Pt 2):80-6. doi: 10.1172/JCI101977.
5
Studies on the chemotherapy of the human malarias; the physiological disposition of pamaquine.人类疟疾化疗研究；帕马喹的生理处置
J Clin Invest. 1948 May;27(3 Pt1):114-20.
6
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VIII. THE PHYSIOLOGICAL DISPOSITION OF PAMAQUINE.人体疟疾化学疗法研究。VIII. 帕马喹的生理处置
J Clin Invest. 1948 May;27(3 Pt 2):114-20. doi: 10.1172/JCI101948.
7
Synthesis of 4-aminoquinoline-1,2,3-triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine hybrids as potential antimalarial agents.合成 4-氨基喹啉-1,2,3-三唑和 4-氨基喹啉-1,2,3-三唑-1,3,5-三嗪杂合体作为潜在的抗疟药物。
Chem Biol Drug Des. 2011 Jul;78(1):124-36. doi: 10.1111/j.1747-0285.2011.01115.x. Epub 2011 Apr 27.
8
Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.4-氨基喹啉-1,3,5-三嗪杂化衍生物的合成、抗疟活性及分子对接
Exp Parasitol. 2015 Oct;157:59-67. doi: 10.1016/j.exppara.2015.06.016. Epub 2015 Jul 9.
9
Antimalarial and antimicrobial activities of 8-Aminoquinoline-Uracils metal complexes.8-氨基喹啉-尿嘧啶金属配合物的抗疟和抗菌活性
EXCLI J. 2016 Feb 18;15:144-52. doi: 10.17179/excli2016-101. eCollection 2016.
10
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. IV. THE METABOLISM OF CINCHONINE IN RELATION TO ITS ANTIMALARIAL ACTIVITY.人体疟疾化学疗法研究。IV. 辛可宁代谢与其抗疟活性的关系。
J Clin Invest. 1948 May;27(3 Pt 2):87-92. doi: 10.1172/JCI101978.
引用本文的文献
1
Hydroxychloroquine-induced Retinal Toxicity.羟氯喹诱导的视网膜毒性。
Front Pharmacol. 2023 May 30;14:1196783. doi: 10.3389/fphar.2023.1196783. eCollection 2023.
2
The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.氯喹和羟氯喹在抗击新型冠状病毒肺炎中的争议性治疗历程：一项综述
Med Drug Discov. 2021 Jun;10:100085. doi: 10.1016/j.medidd.2021.100085. Epub 2021 Mar 10.
3
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.新型冠状病毒肺炎防治：氯喹和羟氯喹临床药理学的批判性分析。
PLoS Med. 2020 Sep 3;17(9):e1003252. doi: 10.1371/journal.pmed.1003252. eCollection 2020 Sep.
4
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.羟氯喹用于合并新型冠状病毒肺炎的风湿性疾病患者：明确目标暴露量及临床试验需求
J Rheumatol. 2020 May 11. doi: 10.3899/jrheum.200493.
5
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.氯喹和羟氯喹在 COVID-19 和其他病毒感染中的治疗用途：叙述性综述。
Travel Med Infect Dis. 2020 May-Jun;35:101735. doi: 10.1016/j.tmaid.2020.101735. Epub 2020 May 6.
6
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.氯喹治疗 2019 新型冠状病毒病：独特的药代动力学和安全性特征的影响。
Clin Pharmacokinet. 2020 Jun;59(6):659-669. doi: 10.1007/s40262-020-00891-1.
7
The past, present and future of anti-malarial medicines.抗疟药物的过去、现在和未来。
Malar J. 2019 Mar 22;18(1):93. doi: 10.1186/s12936-019-2724-z.
8
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.氯喹剂量和伯氨喹对间日疟原虫复发的影响：全球抗疟药物耐药性网络系统评价和个体患者合并荟萃分析。
Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20.
9
Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.泰国疟原虫种群中恶性疟原虫多药耐药 1 基因的遗传多样性。
Infect Genet Evol. 2018 Oct;64:168-177. doi: 10.1016/j.meegid.2018.06.027. Epub 2018 Jun 21.
10
Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report.甲氟喹相关的头晕、复视和中心性浆液性脉络膜视网膜病变：一例报告
J Med Case Rep. 2016 Oct 31;10(1):305. doi: 10.1186/s13256-016-1091-4.
本文引用的文献
1
THE INFLUENCE OF ORALLY ADMINISTERED ALKALI AND ACID ON THE RENAL EXCRETION OF QUINACRINE, CHLOROQUINE AND SANTOQUINE.口服碱和酸对奎纳克林、氯喹和桑托喹的肾脏排泄的影响。
J Clin Invest. 1947 Nov;26(6):1168-72. doi: 10.1172/JCI101909.
Zotero 插件